嶺南股份(002717.SZ)中標3.4億元生態綠化項目
格隆匯4月15日丨嶺南股份(002717.SZ)公佈,日前,公司收到招標人鳳泉湖引黃調蓄工程建設管理局、監督單位新鄉市水利局和招標代理機構河南豫信招標有限責任公司聯合發出的《中標通知書》,確定公司為“新鄉市鳳泉湖引黃調蓄及配套工程(一期)生態綠化項目施工一標段”的項目中標單位。項目估算總投資3.4億元,工期600日曆天。
項目第一標段長約5.05公里,面積約60.42公頃。施工範圍內的園林綠化、道路廣場、功能配套建築、小品構築物、景觀駁岸、給排水、強電、弱電工程、配合設計單位對施工過程中施工圖進行優化提升、缺陷責任期內的質量修復工程等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.